Objective-Atherosclerosis is characterized by frequent communication between infiltrating leukocytes and vascular cells, through chemokine and cytokine networks. Interleukin-17C (IL-17C) is detectable within atherosclerotic lesions; however, the potential involvement of this cytokine has not been examined. Thus, we sought to investigate the role of IL-17C in atherosclerosis. Approach and Results-The expression of IL-17 cytokines was profiled within aortas of apolipoprotein E double knockout (Apoe −/− ) mice, and Il17c expression was elevated. Flow cytometry experiments revealed a major population of aortic IL-17C-producing smooth muscle cells. Next, we generated Il17c −/− Apoe −/− mice and demonstrated that atherosclerotic lesion and collagen content was diminished within Western diet-fed Il17c −/− Apoe −/− aortas and aortic roots in comparison to Apoe −/− controls. Smooth muscle cells and fibroblasts were mainly responsible for the reduced Col1A1 expression in the aorta of Il17c −/− Apoe −/− mice. Importantly, IL-17C-treated Apoe −/− aortas showed upregulated Col1A1 expression ex vivo. Il17c −/− Apoe −/− mice displayed a proportional reduction in aortic macrophages, neutrophils, T cells, T helper 1 cells, and T regulatory cells, without corresponding changes in the peripheral immune composition. Examination of aortic IL-17A + T-cell receptor γδ T cells and Th17 cells demonstrated a stark reduction in the percentage and number of these subsets within Il17c −/− Apoe −/− versus Apoe −/− mice. Explanted 12-week Western diet-fed Apoe −/− aortas treated with IL-17C resulted in the induction of multiple vascular chemokines and cytokines. Th17 cells demonstrated attenuated migration toward supernatants from cultures of Il17c −/− Apoe −/− smooth muscle cells, and short-term homing experiments revealed diminished recruitment of Th17 cells to the aorta of Il17c −/− Apoe −/− recipients. Conclusions-Smooth muscle cell-derived IL-17C plays a proatherogenic role by supporting the recruitment of Th17 cells to atherosclerotic lesions. The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
C ardiovascular diseases are the leading cause of global deaths, and atherosclerosis-associated cardiovascular diseases were responsible for 13.5 million out of 17.3 million cardiovascular diseases worldwide in 2008. 1 The formation of atherosclerotic plaques is a chronic arterial inflammatory process that is characterized not only by the formation of lipid-rich plaques 2 but also by the regular communication between arterial hematopoietic cells and vascular cells through cytokine and chemokine networks. T cells, as a part of the adaptive immune response, actively participate in regulating local and systemic inflammation during atherogenesis. In this respect, the pro-and antiatherogenic roles of interferon γ (IFNγ) + T helper 1 (Th1) and T regulatory (Treg) cells are well established. However, the roles of interleukin-17A (IL-17A) + T cells, including T helper 17 cells (Th17) and IL-17A + T-cell receptor (TCR) γδ T cells, have been controversial, because of conflicting results on the functions of IL-17A in atherosclerosis. [3] [4] [5] [6] [7] [8] The IL-17 cytokine family consists of 6 family members, (IL-17A-IL-17F), which vary in their distribution, biological roles, and sequence homology. 9, 10 The roles and biological functions of IL-17A-and IL-17F-producing cells in inflammation have been well studied. However, the functions of other members of the IL-17 family (IL-17B-D) were unclear until recently. 9 Recent work on the biology of IL-17C has revealed that IL-17C signals through a heteromeric receptor consisting of the interleukin-17 receptor E (IL-17RE) subunit and the common interleukin-17 receptor A (IL-17RA) subunit, 11, 12 which is known to be shared with IL-17A, IL-17F, and IL-17B. IL-17C signaling results in the induction of chemokines and proinflammatory cytokines, including Cxcl1, Cxcl2, Ccl20, Tnf, and Il1b within IL-17RA-and IL-17REexpressing colonic epithelial cells and keratinocytes. 12, 13 Th17 cells that express IL-17RA and IL-17RE upregulate IL-17A, IL-17F, and IL-22 production in response to IL-17C, 11 indicating that IL-17C might play a role in Th17 differentiation or maintenance. Importantly, IL-17RA and IL-17RE are expressed within Apoe −/− aortas, 4 suggesting that the receptor complex for IL-17C signaling is present within the aorta.
Because of the plethora of types of cells that express IL-17RA and IL-17RE, IL-17C is likely to play pleiotropic roles in host defense, autoimmune, or inflammatory pathologies. 11, 14, 15 IL-17C is expressed by colonic epithelial cells and plays key roles in host survival by maintaining mucosal barrier integrity in a Citrobacter rodentium infection model 12 and dextran sulfate sodium-induced colitis models. 13, 16 IL-17C is elevated in psoriatic lesions, and it significantly affects the abundance of F4/80 + macrophages within inflamed psoriatic plaques. 13, 14, 17 Similarly, IL-17C is required for the development of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. In the context of atherosclerosis, recent work from our group demonstrated that several IL-17 cytokines are present within atherosclerotic apolipoprotein E double knockout (Apoe −/− ) mice aortas, 18 including IL-17A, IL-17C, and IL-17F, suggesting that IL-17C might also play a role in atherogenesis.
In addition to IL-17C, IL-17A is an important proinflammatory cytokine that is required to efficiently control bacterial and fungal infections, and also participates in major autoimmune diseases. 9, 19 Several studies have reported elevated levels of Th17 and IL-17A + TCRγδ T cells within atherosclerotic Apoe −/− and Ldlr −/− mice, 3, 18, [20] [21] [22] in patients with coronary artery disease and in endarterectomy patients with vulnerable plaques. 3, 23, 24 However, the precise role(s) that IL-17A plays have been disputed. [3] [4] [5] [6] [7] [8] Mechanistic studies in murine models of atherosclerosis have yielded at least 2 unifying hypotheses, that IL-17A plays a proatherogenic role by affecting aortic chemokine and cytokine production and myeloid cell recruitment 3, 4, 6, 8, 18, 20, 22, 25 or an atheroprotective role via regulation of aortic Th1 content, smooth muscle cell (SMC) content, and collagen deposition. 5, 21, 26 In this study, we hypothesized that in addition to IL-17A, other IL-17 family members might participate in the pathology of atherosclerosis. We report here that aortic IL-17C is elevated within atherosclerotic Apoe −/− mice in comparison to nonatherosclerotic C57Bl6 controls. Aortic SMCs are, unexpectedly, prominent sources of arterial IL-17C within Apoe −/− and C57Bl6 mice. To study the role of IL-17C in atherosclerosis, Il17c −/− Apoe −/− mice were generated. Deficiency of IL-17C resulted in moderate reductions in atherosclerotic lesions, lesional collagen content, aortic leukocyte, macrophage, neutrophil, Th1 and Treg cells, and robustly reduced aortic Th17 and IL-17A + TCRγδ + T cell content, because of defective IL-17C-mediated IL-17A + T-cell recruitment to the aorta. Importantly, these data underscore the significance of communication between aortic IL-17C + SMCs and arterial IL-17A-producing T cells to efficiently promote atherogenesis.
Materials and Methods

Animals
Il17c −/− mice (kindly provided by Amgen, Inc) on the C57Bl6 background were crossed with Apoe −/− mice to generate Il17c −/− Apoe −/− mice. Six-week-old male and female Apoe −/− and Il17c −/− Apoe −/− mice were placed on a high-fat Western diet (21% fat and 0.15% cholesterol, TD.88137; Harlan Laboratories, Indianapolis, IN) for 12 weeks and used at 18 weeks of age. For en face preparations, Apoe −/− and Il17c −/− Apoe −/− littermates from Il17c +/− Apoe −/− breeders were used. Dedicated Il17c −/− Apoe −/− and Apoe −/− breeders were used subsequently because atherosclerotic lesions were equivalent between Apoe −/− mice from Il17c +/− Apoe −/− and Apoe −/− breeders. For the in vitro chemotaxis assays, 40-week-old Il17a iCre/iCre R26R tdTomato/ tdTomato Apoe −/− mice were used. All animals were kept in specific-pathogen-free conditions, and animal experiments were approved by the Eastern Virginia Medical School Animal Care and Use Committee. Unless noted otherwise, all surgical procedures and organ collections were collected aseptically to prevent potential bacterial or fungal contaminants from affecting the results.
An expanded Materials and Methods section is available in the online-only Data Supplement.
Results
IL-17C Is Elevated in Atherosclerotic Apoe −/− Aortas and Is Produced Primarily by Aortic Smooth Muscle Cells
Although several recent studies have examined the role(s) of IL-17A and IL-17F in atherosclerosis, the potential roles of other IL-17 family members have not been explored. To reconfirm 18 that IL-17 cytokine family members are present during atherosclerosis, we initially examined the expression of the IL-17 cytokines in 40-week-old Apoe −/− and C57Bl6 aortas. For all experiments presented in this study, the aortas were cleaned of all periaortic adipose tissue but contained the aortic adventitia. The aortas with surrounding adventitia were used for flow cytometric analysis or reverse transcription-polymerase chain reaction (RT-PCR). Several IL-17 cytokines were present and elevated within aged atherosclerotic Apoe −/− aortas, including Il17a, Il17c, and Il17f ( Figure 1A ). To confirm these results and to determine whether IL-17C expression is altered during atherogenesis, we examined the aortas isolated from 12-week chow diet-fed C57Bl6 and Apoe −/− mice, and the aortas from 12-week WD-fed Apoe −/− mice for IL-17C expression ( Figure 1B ). IL-17C expression was elevated in chow diet-fed atherosclerotic Apoe −/− aortas and was further enhanced in 12-week WD-fed Apoe −/− mice ( Figure 1B ). Next, to determine the sources of aortic IL-17C, we examined 12-week WDfed Apoe −/− aortas for IL-17C expression by flow cytometry Figure 1D ) and PCR ( Figure 1C ). In agreement with reports on the biology of IL-17C within mucosal epithelial cells and keratinocytes, [11] [12] [13] [14] [15] IL-17C was almost exclusively expressed by CD45 − nonhematopoietic cells, but not CD45 + hematopoietic cells, within the aorta of 12-week WD-fed Apoe −/− mice ( Figure 1D ). To determine the nonhematopoietic cellular sources of aortic IL-17C, we developed a scheme for examining and isolating vascular cell components by fluorescence activated cell sorting ( Figure I in the online-only Data Supplement) with a specific focus at IL-17C production within vascular cell subsets ( Figure 1D-1F ). Leukocytes were excluded from the analysis based on CD45 expression, and CD45 − vascular cells were subsequently examined for CD31, αSMA, and CD29 positivity ( Figure I in the online-only Data Supplement). CD45 − CD31 + endothelial cells, CD45 − CD31 − αSMA + SMCs, CD45 − CD31 − αSMA − CD29 + fibroblasts, and CD45 − CD31 − α SMA − CD29 − vascular cells were subgated and examined for IL-17C production ( Figure 1D-1F ). As expected, SMCs and endothelial cells represented the clear majority of vascular cells recovered from aged C57Bl6, Apoe −/− , and 12-week WD-fed Apoe −/− aortas ( Figure 1E ). Interestingly, CD45 − CD31 − αSMA + SMCs and CD45 − CD31 − αSMA − CD29 − vascular cells were the primary producers of IL-17C within the aorta, and a higher percentage of SMCs were IL-17C + within Apoe −/− aortas in comparison to nonatherosclerotic C57Bl6 aortas ( Figure 1F ). To confirm our results using a complimentary technique, we isolated primary Apoe −/− aortic SMCs using magnetic separation from 12-week WD-fed Apoe −/− mice and assessed Il17c expression ( Figure 1C ). In confirmation of our flow cytometric results, Il17c expression was detected in nonhematopoietic cells and further significantly enriched in CD45 − CD31 − CD29 − SMCs ( Figure 1C ). Collectively, these data demonstrate that the vasculature is an important source of IL-17C in atherosclerosis. In addition, these data are the first to report that IL-17C can be detected by flow cytometry using conventional phorbol 12-myristate 13-acetate (PMA)-based restimulation techniques.
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IL-17C-Deficient Conditions Reduce Atherosclerosis and the Number of Aortic Leukocytes and Myeloid Cell Subsets
To directly assess the role of IL-17C in atherosclerosis, we generated Il17c −/− Apoe −/− mice and compared atherosclerotic lesions between 12-week WD-fed Apoe −/− and Il17c −/− Apoe −/− mice. Apoe −/− and Il17c −/− Apoe −/− mice showed no difference in body weight and plasma cholesterol, triglyceride, lowdensity lipoprotein cholesterol, or high-density lipoprotein cholesterol contents between males and females ( Table 1) . Diet-matched Il17c −/− Apoe −/− mice developed 40% smaller lesions throughout the aorta (Figure 2A and 2B) and a 32% reduction in aortic root lesions ( Figure 2C ) in comparison with 12-week WD-fed Apoe −/− littermates. Because some reports have suggested that IL-17A might promote collagen deposition by SMCs 5,21,26 and other reports did not observe any effects of IL-17A on lesional collagen content, 4,6,22 we next sought to determine whether IL-17C might affect lesional SMC or collagen content within the aortic root. Although we did not detect any difference in the percentage of lesional aortic root SMCs ( Figure 2D ), we did detect a 40% reduction in total collagen and type 1 collagen fiber contents ( Figure 2E ; data not shown) in 12-week WD-fed Il17c −/− Apoe −/− mice. To confirm these results and to test whether IL-17C might play a role in promoting collagen deposition, we treated explanted 12-week WD-fed Apoe −/− aortas with or without IL-17C and assessed procollagen expression (Col1a1; Figure 2F ). In this system, IL-17C promoted procollagen expression. To identify the specific cell type that is responsible for the IL-17C-dependent increased collagen synthesis, we isolated primary Apoe −/− and Il17c −/− Apoe −/− populations of CD45 + aortic leukocytes, CD45 − CD31 + endothelial cells, CD45 − CD31 − CD29 − SMCs, and CD45 − CD31 − CD29 + fibroblasts by fluorescence activated cell sorting. The primary cells were then assessed for Col1a1 expression ( Figure 2G ). Col1a1 expression was enhanced in IL-17C-expressing Apoe −/− SMCs and fibroblasts versus IL-17C-deficient Il17c −/− Apoe −/− SMCs and fibroblasts. These data suggest that IL-17C does play a role in promoting procollagen expression in aortic SMCs and fibroblasts, but IL-17C plays a decidedly proinflammatory role in atherosclerosis. The development of atherosclerotic plaques requires active and sustained recruitment of leukocytes into the aortic wall. 27 As previous work from our group 4 demonstrated that the IL-17A/IL-17RA pathway promotes the recruitment of leukocytes to the aorta, notably monocytes and neutrophils, 4, 18 we next sought to characterize the aortic immune composition in Il17c −/− Apoe −/− mice by flow cytometry. In agreement with our en face and aortic root lesion data ( Figure 2 ), Il17c −/− Apoe −/− aortas with the surrounding aortic adventitia displayed a ≈35% reduction in both the percentage and number of aortic CD45 + leukocytes, in comparison to Apoe −/− littermates ( Figure 3A and 3B). To determine whether IL-17C-deficient conditions might impact the abundance of aortic or peripheral myeloid cells and myeloid cell subsets, we examined the percentage and numbers of aortic infiltrating and peripheral CD11b + myeloid cells, CD68 + macrophages, and GR1 + neutrophils. Twelve-week WD-fed Il17c −/− Apoe −/− mice displayed a significant reduction (≈40%) in the percentage and number of aortic CD11b + myeloid cells, CD11b + CD68 ++ macrophages, and CD11b + GR1 ++ neutrophils versus Apoe −/− controls ( Figure 3C and 3D). Because IL-17C is known to be produced by colonic epithelial cells and keratinocytes and IL-17C plays important roles in helping to maintain mucosal immunity, [12] [13] [14] [15] we next determined whether IL-17C-deficient conditions might additionally affect the systemic immune composition. Surprisingly, we did not detect differences in the composition of CD11b + leukocytes, macrophages, neutrophils, Ly6C high monocytes, or Ly6C low monocytes within the blood or spleens of 12-week WD-fed Il17c −/− Apoe −/− and Apoe −/− mice (data not shown), suggesting that the effects seen within the aorta are because of the local effects of IL-17C.
IL-17C Supports the Accumulation of Proatherogenic IL-17A + T Cells Within the Aortic Wall
As recent work by Chang et al 11 demonstrated that both Th17 cells and IL-17A + TCRγδ + T cells express IL-17RA and IL-17RE, the functional receptor for IL-17C, and that IL-17C helps to regulate proinflammatory IL-17A production in a model of experimental autoimmune encephalitis, we next examined the T-cell composition of 12-week WD-fed Il17c −/− Apoe −/− and Apoe −/− mice (Figure 4 ). The percentages of aortic CD3 + and TCRαβ + CD3 + T cells were similar between Il17c −/− Apoe −/− and Apoe −/− mice ( Figure 4A and 4B) ; however, the absolute number of infiltrating aortic CD3 + and TCRαβ + CD3 + T cells were decreased by 60% in Il17c −/− A poe −/− aortas ( Figure 4B ). To determine whether IL-17C might affect the abundance of aortic Th1, Th17, Treg, or cytokineproducing TCRαβ − T cells (which are mostly TCRγδ + T cells within the aorta, additional data not shown) in 12-week WD-fed Apoe −/− and Il17c −/− Apoe −/− aortas, IL-17A and IFNγ cytokine staining was performed ( Figure 4C-4E ). Although the overall percentages of aortic IFNγ + Th1 (Figure 4C and 4D) and Foxp3 + Tregs ( Figure 4D ) were similar between 12-week WD-fed Apoe −/− and Il17c −/− Apoe −/− aortas, the number of these subsets were proportionally lower in Il17c −/− Apoe −/− mice as a consequence of diminished aortic CD3 + T-cell counts ( Figure 4D) . In contrast, we detected a stark reduction (≈70%) in both the percentage and number of aortic CD3 + TCRαβ + Th17 cells ( Figure 4C and 4D) and IL-17A + TCRαβ − T cells ( Figure 4E and 4F) within 12-week WD-fed Il17c −/− Apoe −/− aortas.
Colonic epithelial cells and keratinocytes are also important sources of IL-17C in vivo; thus, we similarly characterized T-cell subsets within the spleens, periaortic lymph nodes, and peripheral lymph nodes of 12-week WD-fed Apoe −/− and Il17c −/− Apoe −/− mice to determine whether a global deficiency of IL-17C might affect peripheral T-cell subsets. Despite diminished aortic Th1 and Treg cellularity and the strong reduction in both the percentage and number of aortic Th17 and IL-17A + TCRαβ − T cells, we did not observe differences in the percentage or number of these subsets in the spleens, periaortic lymph nodes ( Figure II in the online-only Data Supplement), or peripheral lymph nodes (data not shown) of Apoe −/− and Il17c −/− Apoe −/− mice. Together, these data suggest that a global deficiency of IL-17C results in severely impaired accumulation of aortic IL-17A + T cells within the arterial wall and proportionally reduced aortic macrophage, neutrophil, Th1, and Treg cellularity in Apoe −/− mice.
IL-17C Promotes Aortic Chemokine and Cytokine Expression and Helps to Recruit Th17 Cells to Atherosclerotic Plaques
Several studies have shown that IL-17A promotes arterial vascular chemokine and cytokine expression and supports the recruitment of monocytes and neutrophils to atherosclerotic lesions. 3, 4, 18, 20, 23, [28] [29] [30] [31] Thus, we next sought to determine the effects of IL-17C on aortic chemokine and cytokine expression ( Figure 5A ). Twelve-week WD-fed Apoe −/− aortas were explanted for 24 hours with or without IL-17C and assessed for Ccl2, Ccl7, Ccl20, Cx3cl1, Cxcl1, Cxcl2, Cxcl5, Il6, Il23a, and Il1b expression by RT-PCR. In this system, IL-17C broadly supported the expression of these cytokines and chemokines ( Figure 5A ), including the pro-Th17 chemokine Ccl20 and cytokines Il6, Il23, and Il1b. Thus, because IL-17C helped to induce aortic pro-Th17 chemokine and cytokine expression and Il17c −/− Apoe −/− mice displayed a specific reduction in aortic Th17 and IL-17A + TCRαβ − T-cell content (Figure 4 ), we hypothesized that IL-17C + SMCs might support the accumulation of Th17 and IL-17A + TCRαβ − T cells within the arterial wall. To test this hypothesis, we performed IL-17C-dependent Th17 chemotaxis experiments in vitro, in order to clarify whether Th17 cells directly or indirectly migrate to IL-17C. In brief, we generated a new strain of IL-17A lineage tracing Il17a icre/icre R26R tdTomato/tdTomato Apoe −/− mice in our laboratory, in which the expression of IL-17A is detected via R26R tdTomato/tdTomato expression. While IL-17A tdTomato+ CD4 + T cells efficiently migrate to IL-17C-producing Il17c +/+ Apoe −/− aortic SMC supernatants, Th17 cell migration to Il17c −/− Apoe −/− aortic SMC supernatants was significantly reduced ( Figure 5B ). Thus, IL-17C does play a role in supporting the recruitment of Th17 cells in chemotaxis assays. To further examine the role of IL-17C in the regulation of Th17 cell homing in vivo, we adoptively transferred fluorescently labeled Apoe −/− splenocytes to 12-week WD-fed Apoe −/− and Il17c −/− Apoe −/− mice for 72 hours and tracked the migration of Apoe −/− splenic CD4 + and Th17 cells to recipient spleens ( Figure 5C and 5D), periaortic lymph nodes (data not shown), and aortas ( Figure 5E and 5F) . We found an equivalent percentage and number of donor CD4 + T cells and Th17 cells within the spleens (Figure 5C and 5D ) and periaortic lymph nodes (data not shown) of Apoe −/− and Il17c −/− Apoe −/− recipient mice. In contrast, a significantly lower percentage and number of transferred CD4 + T cells and Th17 cells successfully accumulated in the aortas of 12-week WD-fed Il17c −/− Apoe −/− mice versus diet-matched Apoe −/− recipients ( Figure 5E and 5F) . These data demonstrate that IL-17C had no effect on the peripheral maintenance or accumulation of Th17 cells but did affect the accumulation of Th17 cells within the atherosclerotic aortic wall. Therefore, these data demonstrate that IL-17C plays a proatherogenic role by supporting the accumulation of proatherogenic Th17 cells within the aorta, which can in turn affect the recruitment of monocytes and neutrophils to the plaque. 4
Discussion
Regular communication through cytokine and chemokine networks between arterial hematopoietic and vascular cells plays a critical role in atherosclerosis. Various aortic infiltrating cell populations have been described to produce cytokines and chemokines in atherogenesis, and many groups have studied the effects of manipulating or knocking out cytokines in atherosclerosis, as reviewed elsewhere. 27 Recent efforts to examine the role of IL-17A-secreting Th17 cells have been a subject of debate, [3] [4] [5] [6] 8 although Th17 cells are clearly present in both murine and human atherosclerotic plaques. 3, 18, [20] [21] [22] [23] [24] However, the IL-17 cytokine family consists of 5 additional family members (IL-17B-IL-17F), and recent work has demonstrated that IL-17 cytokines may also participate in autoimmune and inflammatory pathologies. Thus, we sought to examine whether other IL-17 cytokines, in addition to IL-17A, might participate in atherogenesis.
We observed here that several IL-17 cytokines are present within atherosclerotic Apoe −/− aortas, including Il17a, Il17c, Il17e, and Il17f. However, Il17c was surprisingly the most abundant IL-17 cytokine within Apoe −/− atherosclerotic aortas, and a significant portion of aortic vascular cells produce IL-17C, ranging from 2% to 12% of the entire aorta. To determine which vascular cells might express IL-17C, we developed a gating scheme to look at different vascular cell subsets and IL-17C production by those subsets via flow cytometry. These experiments revealed that a major population of aortic SMCs produces IL-17C ex vivo. To further confirm these results, we used RT-PCR as a complimentary method to assess the primary sources of IL-17C. Using highly purified populations of CD45 + hematopoietic and sorted subsets of CD45 − nonhematopoietic cells, we demonstrated robust expression of Il17c in SMCs, but not in CD45 + cells. These results are noteworthy for several reasons. To date, the identification of the cellular sources of IL-17C in vivo and the examination of cytokine production within SMCs have been technically limited to Western blot, histological assays, or PCR-based assays. We report here that with a careful gating strategy, aortic SMCs can be examined for cytokine production ex vivo and that IL-17C can be detected by conventional PMA, ionophore-based cytokine flow cytometry techniques. Additionally, the data presented here represent the first report to demonstrate that aortic SMCs are an important source of IL-17C in vivo. SMCs play critical roles in atherosclerosis, not only in stabilizing atherosclerotic plaques through collagen deposition and the formation of fibrous caps but also in promoting inflammation by producing proinflammatory cytokines. 32 Evidence demonstrate that SMCs may assume a proinflammatory phenotype in sterile inflammation and participate in atherosclerosis. SMCs may produce several cytokines and chemokines in atherosclerosis, including proinflammatory IL-8, CCL2, CXCL1, IL-1β, IL-6, atheroprotective IL-19, and now, IL-17C as well. Although the specific mechanisms of IL-17C induction within SMCs remain to be determined, previous work on IL-17C and SMC biology suggested that several pathways might be involved. SMCs respond to oxidized low-density lipoprotein via the lectin-like oxidized low-density lipoprotein scavenger receptor (LOX-1) in culture by producing MCP-1, CXCL1, TNFα, and VCAM-1, [32] [33] [34] likely in an NFκB-, NFAT-, p38-, and JNK-dependent manner; 32 suggesting that oxidized low-density lipoprotein or oxidized lipids might promote IL-17C expression within atherosclerosis as well. Additionally, as PMA and Ionomycin C are known to activate T cells in a PKC-NFκB-, NFAT-, and MAPK-dependent manner, PMA and Ionomycin C stimulation may induce IL-17C expression in aortic SMCs in a PKCdependent manner. In support of this notion, IL-17C is quickly induced within the gut in response to TLR 2 and TLR 5 in an NFκB-dependent manner. 13 Ramirez-Carrozzi et al 13 focused exclusively on the role of IL-17C in mucosal immunity; however, similar mechanisms may be at work in sterile atherogenic inflammation. SMCs express TLR proteins, and TLR2, TLR3, CD36, and TLR4 have been demonstrated to participate in both sterile 35, 36 and infectious atherogenesis. 28, 37 Although the experiments here were conducted sterilely, there are clear links between Porphyromonas gingivalis and Chlamydophila pneumoniae infection, atherosclerosis, and aortic IL-17A + T-cell accumulation. Thus, the potential induction of aortic IL-17C via TLR signaling within SMCs during sterile or infectious atherogenesis may be an important link between the vasculature and the adaptive immune response.
To examine the role of IL-17C in atherosclerosis, we generated Il17c −/− Apoe −/− mice, which exhibited a ≈35% reduction in atherosclerotic lesions in comparison to diet-matched 12-week WD-fed Apoe −/− controls. These results are in line with recent studies on IL-17C-producing cells in the gut and skin, and mechanistic studies in autoimmune pathologies provided insight on the potential mechanisms of action for IL-17C in atherosclerosis. [11] [12] [13] [14] [15] In the context of colitis and psoriasis, epithelial cell-derived and keratinocyte-derived IL-17C induced an array of chemokines that are also IL-17A responsive, such as CXCL1, CXCL2, and CCL20, and supported the local accumulation of F4/80 + macrophages. 13, 14 These studies provided insight on the potential functions of aortic IL-17C in atherosclerosis. Although IL-17C clearly displayed proatherogenic role, IL-17C also supported the synthesis of collagen by SMCs and fibroblasts, highlighting an important aspect of IL-17C biology. IL-17C signals through a heteromeric receptor consisting of the IL-17RE subunit and the common IL-17RA subunit, 11, 12 via the MAPK and NFκB pathways 11 in an Act1-dependent manner. 13 Interestingly, the IL-17C/IL-17RE-IL-17RA and IL-17A/IL-17RC-IL-17RA signaling pathways share several similarities, including the common coreceptor IL-17RA, the adaptor protein Act1, MAPK, and NFκB signaling intermediates, and a set of target transcripts, including IL-1β, IL-6, IL-8, CXCL1, CXCL2, CCL2, and CCL20, suggesting that IL-17C and IL-17A may exert similar actions on myeloid cell and CCL20-dependent Th17 recruitment in vivo. In atherosclerosis, IL-17RA, IL-17RE, and IL-17RC are all expressed, suggesting that IL-17 ligand regulation plays a major role in controlling IL-17 signaling. This notion is in line with previous data that demonstrated that the severity of atherosclerotic plaques corresponded with the presence of IL-17A + T cells in the aortic arches of Apoe −/− mice. 4 Mechanistic studies in murine models of atherosclerosis have yielded at least 2 unifying hypotheses, that IL-17A plays a proatherogenic role by affecting aortic chemokine and cytokine production and myeloid cell recruitment 3, 4, 6, 8, 18, 20, 22, 25 or an atheroprotective role via regulation of aortic Th1 content, SMC content, and collagen deposition. 5, 21, 26 More recent work has further proposed that IL-17A might directly affect activation of vasculature 38 and plaque macrophage functions as well. 39, 40 As Il17c −/− Apoe −/− mice demonstrated an atheroprotective phenotype, with reduced IL-17A + T-cell content and Th17 recruitment to the aorta, and a decrease in total lesional collagen, our findings here further support a proatherogenic role of Th17 cells.
The recruitment of myeloid cells to nascent plaques plays a critical role in the initiation and progression of atherosclerotic plaques, and IL-17A promotes the accumulation of monocytes and neutrophils within atherosclerotic les ions. 3, 4, 6, 8, 18, 20, 22, 25 Thus, we sought to determine whether a global deficiency of IL-17C might affect the aortic or circulating myeloid cell immune composition. These experiments revealed a proportional 40% to 50% decrease in aortic myeloid cells, including macrophages and neutrophils, highlighting a strong correlation between atherosclerotic plaque lesion size and macrophage and neutrophil content within the aortic wall. As IL-17C helps to maintain mucosal immunity and is abundant within the inflamed aorta and skin, 14 it was important to examine whether IL-17C might affect the peripheral immune system. However, the peripheral immune composition was unchanged, suggesting that the local actions of SMC-derived arterial IL-17C were responsible for the protective phenotype of Il17c −/− Apoe −/− mice. As specific Il17c flox/flox mice are not currently available, we used global IL-17C-deficient Apoe −/− mice in this study. Further studies using a SMC-specific IL-17C-deficient mouse model might reveal additional effects of SMC-derived IL-17C on atherosclerosis.
IL-17C has been reported to play a key role in promoting IL-17A production within IL-17RE-expressing Th17 and IL-17A + TCRγδ + T cells and key roles in the pathology of experimental autoimmune encephalitis 11 and psoriasis. 14 We detected here an overall reduction in the total number of aortic infiltrating CD3 + and CD3 + TCRαβ + T cells, Th1 cells, and Treg cells within WD Il17c −/− Apoe −/− mice. However, when we examined Th17 and IL-17 + TCRαβ − T cells, we observed a disproportionate 70% to 80% decrease in the percentage and number of cells within Il17c −/− Apoe −/− aortas versus Apoe −/− controls. Several mechanisms could be responsible for a diminished aortic IL-17A + T-cell response, ranging from defective migration to altered differentiation, proliferation, or survival. We reasoned that if changes in Th17 differentiation, proliferation, or survival were responsible for diminished aortic Th17 content, Il17c −/− Apoe −/− mice would display similar defects peripherally. As peripheral T-cell subsets were unaltered between Il17c −/− Apoe −/− and Apoe −/− mice and IL-17C broadly supported pro-Th17 chemokine/cytokine expression in ex vivo experiments, we hypothesized that aortic IL-17C might support Th17 cell recruitment during atherogenesis. In our adoptive transfer experiments, donor CD4 + IL-17A + Th17 cells did not migrate as well to the aortas of Il17c −/− Apoe −/− versus Apoe −/− recipients. Interestingly, equivalent amounts of donor CD4 + IFNγ + Th1 cells accumulated in Il17c −/− Apoe −/− and Apoe −/− recipient aortas (data not shown).
Thus, these results demonstrate that the reduction of aortic Th17 cells in Il17c −/− Apoe −/− mice are because of the inefficient recruitment of Th17 cells, rather than a defect in T-cell recruitment or peripheral Th17 differentiation or accumulation. Together, these results demonstrate that in sterile conditions, IL-17C is produced and acts locally on the aortic wall to promote proinflammatory chemokines and cytokines and the efficient recruitment of proinflammatory monocytes, neutrophils, and Th17 cells. These observations are important as little is known about the recruitment of Th17 cells in atherosclerosis. Th17 cells are known to express CCR6 and CCR4; however, as Th17 recruitment was unchanged within Ccr6 −/− L dlr −/− mice, CCR6 may not be necessary for the accumulation of aortic Th17 cells. 41 Thus, IL-17C is likely initially produced within the arterial wall and serves to promote the accumulation of Th17 and IL-17A + TCRγδ + T cells. Once Th17 cells migrate to the aortic wall, IL-17A may support the production of proinflammatory chemokines and monocyte and neutrophil recruitment to nascent atherosclerotic plaques, a process that is critical for the initiation and progression of atherosclerotic plaques. 3, 4 Altogether, our data demonstrate a novel proatherogenic role for vascular IL-17C and highlight a dynamic between arterial IL-17C and Th17 and IL-17A + TCRγδ + T cells. These data suggest a model in which aortic IL-17C might act in an autocrine/paracrine manner on nearby vascular cells to support the recruitment of IL-17A + T cells and suggest that in unison, both IL-17A and IL-17C help to recruit additional myeloid cells, thereby affecting the cellularity of atherosclerotic lesions.
